Fact CheckerSign in

NCT07868393Not yet recruiting

Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition From the Emergency Department

Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition From the Emergency Department (PROTECT-ED)

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

The Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition from the Emergency Department (PROTECT-ED) study evaluates an emergency department-based implementation strategy designed to improve delivery of evidence-based overdose and HIV prevention services during community re-entry.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
120 (estimated)
First submitted
5 Oct 2026
Start date
1 Nov 2026
Primary completion date
1 Oct 2027
Lead sponsor
Johns Hopkins University
Diseases
HIV
NCT number
NCT07868393

What you commit to

  • Study type: Interventional
  • Planned participants: 120
  • From 1 Nov 2026 to the primary completion date, 1 Oct 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior enrollment in the PROTECT-ED study.

Other

  • Inability to provide informed consent during the index emergency department encounter.
  • Lack of a reliable telephone number for study follow-up.

Who the study is looking for

  • Are 18 years of age or older.
  • Present to the Johns Hopkins Hospital Emergency Department.
  • Have been released within the previous 180 days from a prison, jail, juvenile detention facility, immigration detention facility, halfway house, residential reentry center, or other correctional setting. Recent incarceration may be confirmed through participant self-report, electronic medical record documentation, the Victim Information and Notification Everyday (VINE) system, or other available documentation. Participant self-report alone is sufficient to establish eligibility.
  • Meet criteria for opioid use disorder or hazardous opioid use and are considered appropriate for evaluation for medications for opioid use disorder (MOUD) or are at risk for HIV acquisition.
  • Able to speak and understand communicate in English sufficiently to provide informed consent and complete study assessments.
  • Provide informed consent.
  • Have a reliable telephone number for study follow-up.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Johns Hopkins Hospital Emergency Department
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.